Comparison of the efficacy of Cognitive-Behavioral Therapy for Perfectionism (CBT-P) versus Unified Protocol for Transdiagnostic Treatment (UP) in the individuals with emotional disorders

Comparison of the efficacy of Cognitive-Behavioral Therapy for Perfectionism (CBT-P) versus Unified Protocol for Transdiagnostic Treatment (UP) in the individuals with clinical perfectionism and anxiety and depressive disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190713044191N1

Enrollment

Registered

2019-09-15

Start date

2017-04-22

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Major depressive disorder, single episode. Condition 2: Major depressive disorder, recurrent. Condition 3: Persistent mood disorders. Condition 4: Social phobia. Condition 5: Panic disorder. Condition 6: Generalized anxiety disorder. Condition 7: Mixed anxiety and depressive disorder. Condition 8: Other mixed anxiety disorders. Major depressive disorder, single episode Major depressive disorder, recurrent Persistent mood [affective] disorders Social phobias Panic disorder Gene

Interventions

Intervention 1: Intervention group 1: Cognitive Behavioral Treatment of Perfectionism (CBT-P): It consists of 12 therapeutic sessions that have been developed step by step based on the protocol propos

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: To have elevated perfectionism, defined by a score greater than 24.7 on the Concern over Mistakes (CM) subscale of the Frost Multidimensional Perfectionism Scale A score greater than18 on the depression (D) and greater than16 on the anxiety (A), subscales of the DAS Scale Diagnosis of one of anxiety disorders or depression at least, based on diagnostic criterias in DSM-5

Exclusion criteria

Exclusion criteria: self-harm behaviors moderate or severe suicidality psychosis drug or substance abuse

Design outcomes

Primary

Measure	Time frame
The general severity of anxiety. Timepoint: At baseline, at the end of treatment, and 3 months after treatment. Method of measurement: Beck Anxiety Inventory.;The general severity of depression. Timepoint: At baseline, at the end of treatment, and 3 months after treatment. Method of measurement: Beck Depression Inventory.;The severity of social anxiety. Timepoint: At baseline, at the end of treatment, and 3 months after treatment. Method of measurement: Connor Social Phobia Inventory (SPIN).;The severity of Panic. Timepoint: At baseline, at the end of treatment, and 3 months after treatment. Method of measurement: Anxiety Sensitivity Inventory (ASI).;The level of perfectionism. Timepoint: At baseline, at the end of treatment, and 3 months after treatment. Method of measurement: The Frost Multidimensional Perfectionism Scale (FMPS).;Emotion regulation strategies. Timepoint: At baseline, at the end of treatment, and 3 months after treatment. Method of measurement: Growth Emotion Regulation Questionnaire (ERQ).;Quality of Life. Timepoint: At baseline, at the end of treatment, and 3 months after treatment. Method of measurement: WHO Quality of Life Questionnaire (WHOQOL).	—

Measure

Time frame

The general severity of anxiety. Timepoint: At baseline, at the end of treatment, and 3 months after treatment. Method of measurement: Beck Anxiety Inventory.;The general severity of depression. Timepoint: At baseline, at the end of treatment, and 3 months after treatment. Method of measurement: Beck Depression Inventory.;The severity of social anxiety. Timepoint: At baseline, at the end of treatment, and 3 months after treatment. Method of measurement: Connor Social Phobia Inventory (SPIN).;The severity of Panic. Timepoint: At baseline, at the end of treatment, and 3 months after treatment. Method of measurement: Anxiety Sensitivity Inventory (ASI).;The level of perfectionism. Timepoint: At baseline, at the end of treatment, and 3 months after treatment. Method of measurement: The Frost Multidimensional Perfectionism Scale (FMPS).;Emotion regulation strategies. Timepoint: At baseline, at the end of treatment, and 3 months after treatment. Method of measurement: Growth Emotion Regulation Questionnaire (ERQ).;Quality of Life. Timepoint: At baseline, at the end of treatment, and 3 months after treatment. Method of measurement: WHO Quality of Life Questionnaire (WHOQOL).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Mahmoodi

Shahid Beheshti University of Medical Sciences

mmahmoodi13@gmail.com+98 21 2303 1548

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026